FDA Grants Second Approval for Pulsed Field Ablation to Boston Scientific
The system is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation and is a new alternative to standard-of-care thermal ablation treatment.
Read More